Calcium channel blocker and Rho-associated kinase activity in patients with hypertension

Journal of Hypertension

Volumn 29, Issue 2, 2011, Pages 373-379

  Hata, Takaki ^a   Soga, Junko ^a   Hidaka, Takayuki ^a   Idei, Naomi ^a   Fujii, Yuichi ^a   Fujimura, Noritaka ^a   Mikami, Shinsuke ^a   Maruhashi, Tatsuya ^a   Kihara, Yasuki ^a   Chayama, Kazuaki ^a   Kato, Hitoshi ^d   Noma, Kensuke ^b   Liao, James K ^e   Higashi, Yukihito ^b,c  

^a Department of Cardiovascular Medicine ^*  (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^d Ten noz Clinic   (Japan)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

amlodipine; calcium channel blocker; hypertension; leukocyte; rho associated kinases

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA TUBULIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOSARTAN; MYOSIN; MYOSIN LIGHT CHAIN PHOSPHATASE; PHOSPHO MYOSIN BINDING SUBUNIT; RHO KINASE; UNCLASSIFIED DRUG;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; WESTERN BLOTTING;

EID: 78651265522     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328340902d     Document Type: Article

References (22)

1. Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 1997; 275:1308-1311.
2. Uehata M, Ishizaki T, Satoh H, Ono T, Kuwahara T, Morishita T, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389:990-994.
3. Hall A. RhoGTPases and the actin cytoskeleton. Science 1998; 279:509-514.
4. Kimura K, Fukata Y, Matsuoka Y, Bennett V, Matsuura Y, Okawa K, et al. Regulation of the association of adducin with actin filaments by Rhoassociated kinase (Rho-kinase) and myosin phosphatase. J Biol Chem 1998; 273:5542-5548.
5. Seasholtz TM, Zhang T, Morissette MR, Howes AL, Yang AH, Brown JH. Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip1) expression in the vasculature of hypertensive rats. Circ Res 2001; 89:488-495.
6. Wehrwein EA, Northcott CA, Loberg RD, Watts SW. Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension. J Pharmacol Exp Ther 2004; 309:1011-1019.
7. Zeng Y, Zhuang S, Gloddek J, Tseng CC, Boss GR, Pilz RB. Regulation of cGMP-dependent protein kinase expression by Rho and Kruppel-like transcription factor-4. J Biol Chem 2006; 281:16951-16961.
8. Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 2001; 38:1307-1310.
9. Liu PY, Chen JH, Lin LJ, Liao JK. Increased Rho kinase activity in a Taiwanese population with metabolic syndrome. J Am Coll Cardiol 2007; 49:1619-1624.
10. Nohria A, Grunert ME, Rikitake Y, Noma K, Prsic A, Ganz P, et al. Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. Circ Res 2006; 99:1426-1432.
11. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lehmann SM, Bertoglio J, et al. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2\+ sensitization of contraction in vascular smooth muscle. J Biol Chem 2000; 275:21722-21729.
12. Kitayama J, Kitazono T, Ooboshi H, Takada J, Fujishima M, Ibayashi S. Longterm effects of benidipine on cerebral vasoreactivity in hypertensive rats. Eur J Pharmacol 2002; 438:153-158.
13. Breitenlechner C, Gassel M, Hidaka H, et al. Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity. Structure 2003; 11:1595-1607.
14. Jarajapu YP, Knot HJ. Relative contribution of Rho kinase and protein kinase C to myogenic tone in rat cerebral arteries in hypertension. Am J Physiol Heart Circ Physiol 2005; 289:H1917-H1922.
15. Savoia C, Tabet F, Yao G, Schiffrin EL, Touyz RM. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens 2005; 23:1037-1045.
16. Del Re DP, Miyamoto S, Brown JH. RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J Biol Chem 2007; 282:8069-8078.
17. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002; 105:1545-1547.
18. Noma K, Rikitake Y, Oyama N, Yan G, Alcaide P, Liu PY, et al. ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. J Clin Invest 2008; 118:1632-1644.
19. Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol 2003; 41:15-19.
20. Fukumoto Y, Mohri M, Inokuchi K, Ito A, Hirakawa Y, Masumoto A, et al. Antiischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina. J Cardiovasc Pharmacol 2007; 49:117-121.
21. Noma K, Goto C, Nishioka K, Jitsuiki D, Umemura T, Ueda K, et al. Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness. J Am Coll Cardiol 2007; 49:698-705.
22. Nohria A, Prsic A, Liu PY, Okamoto R, Creager MA, Selwyn A, et al. Statins inhibit Rho kinase activity in patients with atherosclerosis. Atherosclerosis 2009; 205:517-521.